Statizoid

Health in Africa (WHO region)

174 indicators covering health for Africa (WHO region).

IndicatorLatest Year10-yr change Rank
ndx - number of people dying between ages x and x+n 4,870 2021 down 21.0% 1st
Cases started on MDR-TB treatment 21,264 2024 up 24.8% 8th
Raised fasting blood glucose (>=7.0 mmol/L) 7.1 2014 up 24.6% 10th
Raised fasting blood glucose (>= 7.0 mmol/L) 5.1 2014 up 24.4% 11th
Reported number of people requiring interventions against NTDs 510.99 million 2024 down 13.9% 3rd
Births attended by skilled health personnel 74.1% 2025 up 25.6% 7th
Percentage of total deaths due to NCDs overall and percentage of 54.48 2019 down 17.3% 1st
Low birth weight prevalence 13.7% 2020 down 5.5% 8th
Inactivated first-dose polio vaccine (IPV1) immunization coverage 77.0% 2025 up 285.0% 10th
Low birth weight number 5,356 2020 up 9.7% 6th
Number of current cigarette smokers, estimate 49.09 million 2030 up 11.2% 7th
Reported number of children receiving antiretroviral therapy 590,000 2025 down 16.9% 2nd
New or unknown treatment history cases: Pulmonary, bacteriologically 1.10 million 2023 up 85.6% 4th
Number of children aged 6-59 months with anaemia 102,515 2019 up 15.6% 3rd
Prevalence of anaemia in children aged 6-59 months 60.2% 2019 down 5.0% 1st
HIV-positive TB patients on ART (antiretroviral therapy) 96.0% 2024 up 23.1% 2nd
Treatment success rate for patients treated for MDR-TB 74.0% 2022 up 39.6% 5th
Treatment success rate: HIV-positive TB cases 82 2023 up 17.1% 3rd
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 60.0% 2025 — 11th
International Health Regulations core capacity scores, SPAR version 41 2025 — 7th
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 down 100.0% 3rd
Estimated number of malaria deaths 578,766 2024 up 5.2% 2nd
Number of prevalent tuberculosis cases 3.20 million 2014 up 10.3% 4th
Estimated malaria incidence 237.61 2024 down 2.7% 1st
Estimated malaria mortality rate 51.94 2024 down 19.1% 1st
Japanese encephalitis - number of reported cases 0 2025 — 7th
Number of pregnant women living with HIV who received antiretrovirals 850,000 2025 down 14.1% 2nd
Neonates protected at birth against neonatal tetanus (PAB) 80.0% 2022 up 6.7% 11th
Percentage of people living with HIV who know their HIV status 90 2025 up 25.0% 1st
Percentage of people living with HIV who know their status receiving 92 2025 up 33.3% 1st
Population with basic handwashing facilities at home 20.0% 2024 up 26.9% 5th
Tuberculosis - new and relapse cases 1.37 million 2011 up 56.1% 5th
Estimated number of pregnant women living with HIV needing 940,000 2025 down 21.7% 2nd
Total number of notified TB cases 1.34 million 2014 up 8.3% 6th
Estimated number of pregnant women living with HIV 90 2025 up 9.8% 2nd
Smear-positive tuberculosis treatment-success rate 82.0% 2011 up 17.1% 7th
Insufficiently active 85.4 2016 down 0.5% 3rd
Number of presumed malaria cases 12.99 million 2021 down 72.0% 2nd
Number of indigenous malaria cases 160.59 million 2021 up 67.0% 2nd
Number of confirmed malaria cases 161.97 million 2021 up 68.5% 2nd
Total number of  malaria cases 174.96 million 2021 up 22.8% 2nd
Yellow fever vaccine (YFV) immunization coverage among 1-year olds 50.0% 2025 up 22.0% 6th
Number of indigenous P. falciparum malaria cases 146.86 million 2021 up 238.5% 2nd
Preterm birth rate 10.07 2020 up 0.3% 6th
Preterm birth 3.90 million 2020 up 17.0% 6th
Percentage of people living with HIV receiving treatment who have 95 2025 up 14.5% 3rd
Number of malaria positive cases by rapid diagnostic test 139.84 million 2021 up 77.6% 2nd
Treatment success rate: XDR-TB cases 56 2022 up 180.0% 10th
Confirmed cases of MDR-TB 18,146 2012 up 642.2% 6th
Number of indigenous P. vivax malaria cases 301,399 2021 down 55.9% 4th
Number of people protected from malaria by indoor residual spraying 57.40 million 2021 down 20.5% 2nd
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 89.0% 2014 down 10.1% 2nd
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) 27.0% 2025 — 4th
Confirmed cases of MDR-TB started treatment for MDR-TB 42.0% 2012 — 10th